Rebel Allergan investors demand C-suite shakeup after 'half-hearted' strategic review
admin 5th June 2018 Uncategorised 0After Allergan announced it’s planning to sell its women’s health and infectious disease units, some investors still aren’t happy. They’re so upset, in fact, that they’re calling for a shakeup at the top—and that could mean a CEO switch.
More: Rebel Allergan investors demand C-suite shakeup after 'half-hearted' strategic review
Source: fierce